Anosmia Market | Business Growth, Development Factors, Current and Future Trends till 2029

 For those planning market entry or expansion, this report lays out critical data and expert analysis on the anosmia industry landscape.

 

 Anosmia Market Analysis & Forecast: 2025–2029
 The anosmia market size has grown strongly in recent years. It will grow from $3.55 billion in 2024 to $3.86 billion in 2025 at a compound annual growth rate (CAGR) of 9.0%. The growth in the historic period can be attributed to growing incidence of anosmia cases, increasing number of anosmia cases, rising research grants and research activities for drug development for anosmia, increasing demand for healthcare, and research activities for drug development for anosmia.
 
 The anosmia market size is expected to see strong growth in the next few years. It will grow to $5.54 billion in 2029 at a compound annual growth rate (CAGR) of 9.4%. The growth in the forecast period can be attributed to rising prevalence of chronic diseases, increase in funding from private and government organizations, development of pharmaceutical manufacturing segments, rise in R&D activities for drugs, and rise in therapeutics for anosmia acts. Major trends in the forecast period include technological advancements, advanced treatment for anosmia, increase in funding from private and government organizations, and development of advanced pharmaceutical manufacturing.
 
 Get your free sample today:
 https://www.thebusinessresearchcompany.com/sample.aspx?id=18224&type=smp
 
 What Are The Factors Driving The Anosmia Market?
 The rising incidence of neurological disorders is expected to propel the growth of the anosmia market going forward. Neurological disorders encompass a broad range of conditions that affect the nervous system, including the brain, spinal cord, and nerves throughout the body. The rising incidence of neurological disorders is due to an aging population and the increased prevalence of chronic diseases such as diabetes and hypertension. Neurological disorders can cause anosmia by damaging the olfactory pathways or regions in the brain responsible for processing smell, leading to a loss of the ability to detect or perceive odors. For instance, in March 2023, according to the Alzheimer’s Association, a US-based nonprofit voluntary health organization, 6.7 million Americans aged 65 and older are living with Alzheimer’s dementia, with projections indicating this could rise to 13.8 million by 2060. Thus, the rising incidence of neurological disorders is driving the growth of the anosmia market. 
 
 What Segments Are Covered In The Anosmia Market Report?
 The anosmiamarket covered in this report is segmented — 
 
 1) By Type: Idiopathic Anosmia; Congenital Anosmia
 2) By Treatment: Therapies; Medications
 3) By End User: Hospitals; Clinics; Other End Users
 
 Subsegments:
 1) By Idiopathic Anosmia: Partial Idiopathic Anosmia; Complete Idiopathic Anosmia 
 2) By Congenital Anosmia: Isolated Congenital Anosmia; Syndromic Congenital Anosmia (Associated With Other Conditions Or Syndromes)
 
 What Are The Main Trends, Positively Impacting The Growth Of Anosmia Market?
 Major companies operating in the anosmia market are focusing on developing innovative products, such as smell training kits, to provide effective and non-invasive treatment options for individuals suffering from loss of smell. Smell training kits are sets of materials designed to help individuals improve or regain their sense of smell, especially after experiencing conditions like anosmia (loss of smell) due to various causes such as viral infections or head trauma. For instance, in March 2022, Gousto, a UK-based meal kit manufacturer, launched Flavor Savior smell training kits to help people who lost their sense of smell and taste due to anosmia. The kits are aimed at assisting people to fall back in love with food by stimulating the smell receptors and supporting the recovery of their sense of smell and taste.
 
 Which Are The Major Players Operating In The Global Anosmia Market?
 Major companies operating in the anosmia market are Pfizer Inc., Johnson & Johnson, F. Hoffmann-La Roche AG, Merck & Co. Inc., AbbVie Inc., Bayer AG, Sanofi SA, Bristol-Myers Squibb and Company, AstraZeneca plc, Abbott Laboratories, Novartis AG, GlaxoSmithKline PLC, Takeda Pharmaceutical Company Limited, Eli Lily and Company, Gilead Sciences Inc., Viatris Inc., Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals Inc., Biogen Inc., Astellas Pharma Inc., Sun Pharmaceutical Industries Ltd., Torrent Pharmaceuticals Ltd., Aurobindo Pharma Limited, Cipla Inc., Alphapharm Pty. Ltd., Alde Medi Impex Ltd. 
 
 View the full anosmia market report here:
 https://www.thebusinessresearchcompany.com/report/anosmia-global-market-report
 
 Anosmia Market Regional Insights:
 North America was the largest region in the anosmia market in 2024. Asia-Pacific is expected to be the fastest-growing region in the market going forward. The regions covered in the anosmia market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
 
 Contact Us:
 
 The Business Research Company 
 
 https://thebusinessresearchcompany.com/ 
 
 Americas +1 310–496–7795
 Asia +44 7882 955267 & +91 8897263534
 Europe +44 7882 955267 
 
 Email: info@tbrc.info 
 
 
 Follow Us On:
 
 LinkedIn: https://in.linkedin.com/company/the-business-research-company